niacinamide has been researched along with Coronary Artery Disease in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Secondary hyperparathyroidism has a significant impact on morbidity and mortality due to skeletal and extraskeletal manifestations." | 6.44 | Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan. ( Iseki, K, 2008) |
| "Atherosclerosis is identified as the formation of atherosclerotic plaques, which could initiate the formation of a blood clot in which its growth to coronary artery can lead to a heart attack." | 2.58 | N1-methylnicotinamide (MNAM) as a guardian of cardiovascular system. ( Fattahi, A; Jodati, AR; Latifi, Z; Mihanfar, A; Nejabati, HR; Nouri, M; Pezeshkian, M; Safaie, N; Valiloo, M, 2018) |
| "Secondary hyperparathyroidism has a significant impact on morbidity and mortality due to skeletal and extraskeletal manifestations." | 2.44 | Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan. ( Iseki, K, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nejabati, HR | 1 |
| Mihanfar, A | 1 |
| Pezeshkian, M | 1 |
| Fattahi, A | 1 |
| Latifi, Z | 1 |
| Safaie, N | 1 |
| Valiloo, M | 1 |
| Jodati, AR | 1 |
| Nouri, M | 1 |
| Liu, M | 2 |
| He, A | 1 |
| Chu, J | 2 |
| Chen, C | 1 |
| Zhang, S | 1 |
| He, Y | 1 |
| Tao, W | 1 |
| Lu, M | 1 |
| Hua, M | 1 |
| Ju, W | 2 |
| Fang, Z | 1 |
| Gu, Y | 1 |
| Shi, H | 1 |
| Zhang, R | 1 |
| Wang, L | 1 |
| Chen, J | 1 |
| Shen, L | 1 |
| Yu, P | 1 |
| Chen, X | 1 |
| Wang, Z | 1 |
| Iseki, K | 1 |
2 reviews available for niacinamide and Coronary Artery Disease
| Article | Year |
|---|---|
N1-methylnicotinamide (MNAM) as a guardian of cardiovascular system.
Topics: Atherosclerosis; Cardiovascular System; Coronary Artery Disease; Epoprostenol; Humans; Lipid Droplet | 2018 |
Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
Topics: Calcinosis; Calcium; Chelating Agents; Cinacalcet; Coronary Artery Disease; Ethanol; Humans; Hyperpa | 2008 |
2 other studies available for niacinamide and Coronary Artery Disease
| Article | Year |
|---|---|
Serum N
Topics: Aged; Asian People; China; Chromatography, Liquid; Coronary Artery Disease; Echocardiography, Dopple | 2018 |
Serum N1-Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients.
Topics: Aged; Biomarkers; Body Mass Index; China; Chromatography, Liquid; Comorbidity; Coronary Angiography; | 2017 |